Earth Science Tech (ETST) Total Non-Current Liabilities (2019 - 2025)

Earth Science Tech (ETST) posted Total Non-Current Liabilities of $69305.0 for Q1 2025, down 97.09% on a QoQ basis from $2.4 million in Q4 2024, and down 52.37% year-over-year from $145509.0 in Q1 2024.

Earth Science Tech (ETST) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends

Earth Science Tech's Total Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $69305.0 for Q1 2025.

  • Quarterly Total Non-Current Liabilities fell 52.37% year-over-year to $69305.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $69305.0 (down 52.37% YoY) and the FY2025 annual result came in at $69305.0, down 52.37% from the prior year.
  • Total Non-Current Liabilities was $69305.0 for Q1 2025 at Earth Science Tech, down from $2.4 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $2.4 million in Q4 2024 and bottomed at $69305.0 in Q1 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Earth Science Tech 41.03 Mn 38.90 Mn 6.27 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 69,305.00
Dec 31, 2024 2.38 Mn
Sep 30, 2024 1.80 Mn
Jun 30, 2024 1.55 Mn
Mar 31, 2024 145,509.00
Jun 30, 2019 3,734.00